Overview

The Effects of ECMO on the Pharmacokinetics of Hydromorphone

Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to establish a population pharmacokinetic (PPK) model of hydromorphone in patients under ECMO, and to recommend a dosing regimen when the target effective concentration was reached.
Phase:
Phase 2
Details
Lead Sponsor:
Wuhan Union Hospital, China
Treatments:
Hydromorphone